AfoliOpen Afoli →

Insulin aspart

Insulin aspart is an active ingredient of the class «insulin analog».

Open in Afoli Medicines →

Pharmaceutical drug

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

NOVOLOG MIX 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: NOVOLOG MIX 70/30 is not recommended for the treatment of diabetic ketoacidosis.

US label

Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

EMA

How it works

Class: insulin analog

Common side effects

The trial was a three-month, open-label trial in patients with type 1 or type 2 diabetes who were treated twice daily (before breakfast and before supper) with NOVOLOG MIX 70/30. Table 1: Adverse Reactions that Occurred in ≥ 5% of Type 1 Diabetes Mellitus Adult Patients Treated with NOVOLOG MIX 70/30 NOVOLOG MIX…

US label

Who should not take it

NOVOLOG MIX 70/30 is contraindicated: During episodes of hypoglycemia In patients with hypersensitivity to NOVOLOG MIX 70/30 or one of its excipients Do not use during episodes of hypoglycemia.

US label

Pregnancy and breastfeeding

There are no available data with NOVOLOG MIX 70/30 in pregnant women to inform a drug-associated risk for major birth defects and miscarriage.

Excerpts from the US prescribing label (public domain), copied without changes.

Interactions

Recorded interactions from open sources (Wikidata, US labels). The list is not complete — ask a pharmacist.

Brand names

United States

Fiasp · Fiasp Flextouch · Fiasp Penfill · Novolog · Novolog Flexpen · Novolog Flextouch · Novolog Innolet · Novolog Penfill

European Union

Dazparda · Fiasp · Insulin aspart Sanofi · Kirsty (previously Kixelle) · NovoMix · NovoRapid

Canada

Fiasp · Kirsty · Novorapid · Trurapi

Other trade names

Ins novorapid

Approval status

US Food and Drug Administration
prescription · since 2000
European Medicines Agency
authorised · since 1999
Health Canada
prescription · marketed
First approval anywhere
1999

Codes

ATC
A10AB05, A10AD05
RxNorm CUI
51428
ChEMBL
CHEMBL1201496
PubChem CID
118984445
Wikidata
Q2754775

Frequently asked questions

What is Insulin aspart used for?

Insulin aspart is used for: Maturity-onset diabetes of the young type 2, Hyperglycemia, Type-1 diabetes, and Diabetes.

What kind of medicine is Insulin aspart?

Insulin aspart is an active ingredient of the class «insulin analog».

What are the brand names of Insulin aspart?

Brand names of Insulin aspart include Fiasp, Fiasp Flextouch, Fiasp Penfill, Novolog, Novolog Flexpen, Novolog Flextouch, Novolog Innolet, and Novolog Penfill.

Medicines in the same class

Sources and licences

Updated November 15, 2026